Effects of angiotensin II receptor blockers on serum levels of epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids in patients admitted to a cardiovascular center

PURPOSE: Several clinical studies have demonstrated that angiotensin-converting enzyme inhibitors, but not angiotensin II receptor blockers (ARBs), reduce the risk of non-fatal myocardial infarction and cardiovascular mortality. We found that ARBs inhibited the activity of various cytochrome enzymes...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Yuka, Senda, Asuna, Mukai, Yuji, Yamashita, Miki, Sasaoka, Yuki, Hanada, Minayo, Hongo, Fuminori, Hirokami, Mitsugu, Rane, Anders, Inotsume, Nobuo, Toda, Takaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Pharmacokinetics and Disposition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128744/
https://www.ncbi.nlm.nih.gov/pubmed/33409683
http://dx.doi.org/10.1007/s00228-020-03061-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128744/
https://www.ncbi.nlm.nih.gov/pubmed/33409683
http://dx.doi.org/10.1007/s00228-020-03061-1

Ejemplares similares